We Innovate

Following 4 years and high investment in R&D, our innovative AI-powered technology delivers accurate, fast, and affordable screening for genetic conditions at scale.

What sets gMendel® apart is its scalability and focus on mass genetic screening rather than individual diagnostics.

Our contribution

  • Launch a reliable, safe, rapid & scalable technology for screening genetic conditions
  • Outstand conventional sequencing tech at multiple levels, such as detection & sensitivity, complexity, cost & support environment
  • Reduce healthcare costs for patients & national health systems
  • Reduce energy consumption by 40,000 KWh/year per lab
  • Reduce plastic consumption by 1,050 kg/year per lab